About Panakeia

Panakeia builds artificial intelligence software that delivers comprehensive molecular biomarker profiling directly from standard tissue images. The platform eliminates the need for multiple laboratory tests, providing results in minutes rather than weeks, which enables faster clinical decisions for cancer patients and accelerates drug development research. The company serves hospital pathology departments and pharmaceutical researchers by making precision diagnostics accessible without expensive specialised equipment. Panakeia's technology analyses H&E-stained tissue samples, the most common type used in cancer diagnosis, meaning it integrates into existing workflows without requiring new infrastructure or training.